1. HCN2 Channel-Induced Rescue of Brain Teratogenesis via Local and Long-Range Bioelectric Repair
- Author
-
Vaibhav P. Pai, Salvador Mafe, Javier Cervera, Valerie Willocq, Emma K Lederer, and Michael Levin
- Subjects
0301 basic medicine ,teratogen ,Morphogenesis ,Xenopus ,regenerative medicine ,Endogeny ,Biology ,Regenerative medicine ,lcsh:RC321-571 ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,non-local ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Ion channel ,Original Research ,Mechanism (biology) ,Embryo ,biology.organism_classification ,Embryonic stem cell ,Cell biology ,long-range ,030104 developmental biology ,bioelectric ,Cellular Neuroscience ,ion channel ,030217 neurology & neurosurgery ,nicotine - Abstract
Embryonic exposure to the teratogen nicotine results in brain defects, by disrupting endogenous spatial pre patterns necessary for normal brain size and patterning. Extending prior work in Xenopus laevis that showed that misexpression of ion channels can rescue morphogenesis, we demonstrate and characterize a novel aspect of developmental bioelectricity: channel-dependent repair signals propagate long-range across the embryo. We show that distal HCN2 channel misexpression and distal transplants of HCN2-expressing tissue, non-cell-autonomously reverse profound defects, rescuing brain anatomy, gene expression, and learning. Moreover, such rescue can be induced by small-molecule HCN2 channel activators, even with delayed treatment initiation. We present a simple, versatile computational model of bioelectrical signaling upstream of key patterning genes such as OTX2 and XBF1, which predicts long-range repair induced by ion channel activity, and experimentally validate the predictions of this model. Our results and quantitative model identify a powerful morphogenetic control mechanism that could be targeted by future regenerative medicine exploiting ion channel modulating drugs approved for human use.
- Published
- 2020